# A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.

> **NCT07272642** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Radiopharm Theranostics, Ltd** · enrollment: 16 (estimated)

## Conditions studied

- Imaging
- Colorectal Cancer
- Head and Neck Squamous Cell Carcinoma
- Non-Small Cell Lung Cancer
- Triple Negative Breast Cancer (TNBC)

## Interventions

- **DRUG:** LNTH-2403

## Key facts

- **NCT ID:** NCT07272642
- **Lead sponsor:** Radiopharm Theranostics, Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-30
- **Primary completion:** 2027-08-30
- **Final completion:** 2027-10-31
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07272642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07272642, "A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07272642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*